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Abstract:  
 
The folate receptor has achieved great importance for use in targeted drug delivery and in vitro 
and in vivo diagnostic assays1-2. The folate receptor (FR) is over expressed on several cancer cell 
types and activated macrophages, but exists in relatively low abundance on the surface of non-
cancerous tissue and non inflammatory cells. This unique attribute is the hallmark of folate – 
targeted methodologies allowing the diagnostic agent and/or drug to be ferried to the specific 
disease sites while preventing “off target” effects in normal tissues3-4. Although several folate-
based dyes have been reported, simple and detailed synthetic and purification methods for these 
conjugates have not been reported. Our objective is to develop a new folate-based dye and the 
corresponding HPLC methods for the purification and analysis of this conjugate. Folate-
DylightTM 800 was successfully synthesized by very simple, inexpensive and safe method. The 
whole synthesis method can be performed in small laboratories with minimum resources and 
small quantity of reagents required. The synthesis of Folate-DylightTM 800 conjugate was 
successfully purified by HPLC. The purified Folate-DylightTM 800 conjugate was evaluated by 
microplate reader,  UV-Vis and HPLC.  
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Introduction:  
 
Folic Acid: (Figure: 1) 
Folic acid or vitamin B9 is a water soluble vitamin. Folic acid itself is inactive in the 
body. The reduced form i.e. Tetrahydrofolate (THF) plays an important role in the metabolic 
reactions of the body. It is necessary for the normal growth and maintainance of cells because it 
acts as a coenzyme for DNA and RNA synthesis.5-6 Folate is very important for pregnant women 
as they help in the reproduction of cells in the foetus. Deficiency of folic acid affects the cell 
division and protein synthesis and therefore causes impairment of growth. Folic acid (Vit B9) 
along with Cyanacobalmine (Vit B12) causes conversion of homocysteine to methionine and 
thereby reducing the blood levels of homocysteine and thus decreasing the risk of heart 
diseases.7 It maintains nervous system’s integrity by involving in the production of 
neurotransmitters like serotonin which regulate mood, sleep and appetite. It also decreases 
urinary tract infections. Neural tube effects can be decreased if the pregnant women include folic 
acid into their dietary supplement8-9. Low levels of folic acid cause cancers of cervix, colon and 
lung. High homocysteine levels also weaken the bones causing the bones to fracture. Red blood 
cells are particularly susceptible to folic acid deficiency; hence causing anaemia10. Folate is also 
required in the metabolism of amino acids like histidine, serine, glycine and methionine. 
 
Folate receptor: 
Folate receptors are present on the cell surface. They are surface glycoprotein with high 
affinity for folic acid and folate, which capture the folate from the extracellular liquid and 
transports to the cell11-12. The folate receptors are present on the normal cells, however there is 
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greater receptor presence on malignant cells coupled with the fact that only unique GPI 
(glycosylphosphatidyinositol  anchored folate receptor is the only form capable of uptake of 
folate conjugated species (reduced folate carrier is incapable of uptake of polate conjugates). 
This characteristic of malignant cells can be useful for the diagnosis of cancer13-14. Folate 
receptors can be used for many kinds of folate conjugates like targeted drug delivery for cancer 
treatment and attached conjugate will not release and will not be degraded. Within the endosome, 
the folate  imaging agent conjugate is released from the folate receptor. 
 
Folate Conjugates: 
 Folate can be coupled with different molecules including chemotherapeutic agents, protein 
toxins, immunotherapeuticsagents, antisense oligonucleotides; liposomes entrapped drug, 
polymeric drug carrier and imaging agents.15 Imaging agents can be conjugated to folic acid 
using variety of linkers and cleavable bonds without affecting the binding affinity of the folate 
moiety to the folate receptor. (Figure: 2 shows the schematic representation of folate-dye 
conjugates) Peptides or carbon chain can be used as spacer depending upon size of imaging 
agent.16-17 Folate based conjugates have very good penetration power due to its low molecular 
weight as compared to antibodies. Production cost of antibodies is very high which leads to 
higher cost for in vivo as well as in vitro diagnosis.18 
 
Folate receptor pathway: 
Folate-conjugates bind folate receptor with high affinity19-20 and are subsequently 
internalized into endosomes and that can reduce disulfide bonds. In the absence of any cleavage 
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bond, the attached conjugate will not release and will not be degraded. Within the endosome, the 
folate imaging agent conjugate is released from the folate receptor (Figure-3). 
 
Dylight 800 Maleimide: 
The DyLight 800 family of fluorescent dyes are produced by Dyomics  in collaboration 
with Thermo Fisher Scientific. DyLight dyes are typically used in biotechnology and research 
applications as biomolecule, cell and tissue labels for fluorescence microscopy, cell 
biology or molecular biology. 
Historically, fluorophores such as fluorescein, rhodamine, Cy3 and Cy5 have been used 
in a wide variety of applications. These dyes have limitations for use in microscopy and other 
applications that require exposure to an intense light source such as a laser, because they 
photobleach quickly (however, lifetimes can be increased at least 10 fold using oxygen 
scavenging protocols). DyLight Fluors have comparable excitation and emission spectra and are 
more photostable, brighter, and less pH -sensitive. The excitation and emission spectra of the 
DyLight Fluor series covers much of the visible spectrum and extends into the infrared region, 
allowing detection using most fluorescence microscopes, as well as infrared imaging systems. 
• Dylight 800 products (Table-1). 
• Dylight 800 properties and applications (Figure-4). 
Thermo scientific Dylight 800 is near-IR flour that is invisible to the naked eye but increases 
the staining options when using infrared imaging systems. Dylight 800 has spectral properties21-
24
 that are very similar to other near-IR dyes, including Alexa Fluor*790 and IR*Dye 800, and 
has high solubility for maximal incorporation of the dye into the biomolecule of interest. 
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Physical properties of Thermo Scientific DyLight 800 dye: 
Physical characteristics of Thermo Scientific Dylight 800 dye, including excitation/emission 
spectra, emitted color, extinction coefficient, the correction factor used to quantitate labeled 
protein, the molecular weight of the dye and comparable commercial dyes. Right panel: 
Excitation (black) and emission (brown) spectra for Thermo Scientific Dylight 800 dye25-26 
(Figure-4).  
 
Thermo Scientific Dylight 800 derivatives for a broad range of applications:27-28 
Dylight 800 reactive derivatives for labeling: 
• Amine-reactive dye (N-hydroxysuccinimide (NHS) ester-activated). 
• Sulfhydryl-reactive dye (Maleimide-activated). 
• Free acid dye – non reactive; used as negative control. 
Dylight 800-cinjugated fluorescent probes: 
• Secondary antibody-conjugated- Goat Anti-Mouse or Anti-Rabbit. 
• Streptavidin-conjugated. 
• Neutravidin protein-conjugated. 
Additional fluorescene-based applications: 
• In-Cell ELISA Near Infrared Detection Kit. 
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Materials and Instrumentation used for Synthesis: 
 
1. DyliDghtTM 800 Meleimide is the main product 1mg,Store at -2000C Product#46621, 
Lot#KK12610414 
2. DMSO: Sigma Aldrich, 99% purity; Folate Cysteine: Provided by Dr. Henne ; 
Fluorescein sodium salt(C20H10Na2O5) : Lot# 079K0141V; Multichannel pipetter : 
RAININ , 20-300µl; 
3. UV Plates: BD Falcon microtest 96 well 370µl clear plate, UV Vis transparent film 
bottom, 
4. Non-sterile, no lid, lot No:E1002007; Regular Plates: Generic Bio-One, microplate, 
96well flat bottom, Lot No: E091006L; Spin Filters : Sigma Aldrich, Amicon ultra 0.5 
centrifugal filter, 
5. 3 kDa, Batch No:3110; PD-10 Columns: sephadex G-25M columns, contains 0.15% 
Kathon CG in DI H20, lot no. 393861; Centrifuge: Beckman CS-15R Centrifuge at 8898 
RPM for 12 mins. 
6. UV Plate Reader and BCA assay Software: Gen 5.1.10 Biotek, Epoch. 
7. DIPEA (N,N-Diisopropylethylamine) 
8. Synthesized Folate – Peptide (Folate-Asp-Arg-Asp-Asp-Cys-SH supplied by W. Henne), 
Dylight 800 maleimide was supplied by Thermo Scientific, 99% DIPEA ( N,N-
Dissopropylethylamine) supplied by Aldrich chemicals, DMSO ( Dimethylsulfoxide) 
supplied by fischer swcientific. 
9. HPLC instrumentation and UV-visible spectrophotometer. 
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Synthesis of Folate-dylight 800: 
 1 mg Dylight 800 maleimide was dissolved in 200 ul dimethylsufoxide. 2 mg of folate 
peptide cysteine and 10 ul of DIPEA (N,N-Diisopropylethylamine) were added and mixed 
overnight by magnetic stirrer (at room temperature). The product was purified by reverse phase 
HPLC and analyzed by Fluorescence, UV-Vis spectrophotometer and microplate reader. The 
synthesis of Folate-Dylight 800 maleimide is shown in (figure -5). 
 
Preparation of Buffers: 
Take 0.45 g of ammonium bicarbonate and add 500 ml of distilled water and then stir to 
dissolve (10 mM bicarbonate buffer, pH ~ 6.8).   
 
Experimental Parameters for HPLC: 
The analysis of synthesized product was done by HPLC (Hewlett Packard, series1050) 
with YMC, HPLC column with particle size 6µm and dimension 4.6 x 150 mm. Purification was 
done by Rigel HPLC with particle size 5 µm and column dimension 10 x 250 mm. 
Solvents used: ammonium bicarbonate/acetonitrile  
Flow rate is 1 ml/min 
Detector: DAD with scanning range 200-600  
Method used is BIOTINRH.M 
Gradient method for folate-Dylight conjugates purification (HPLC) 
Time(min) % B 
0.00 1 
1.00 1 
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20.0 99 
40.0 99 
41.0 99 
50.0 99 
52.0 1 
60.0 1 
 
Experimental parameters for UV-Visible spectrophotometer 
EPOCH - U.V sample 
Start at 220 nm 
End at 900 nm. 
 
Results and Discussion: 
The synthesis of Folate –DylightTM 800 was a very simple and quick method. In this 
method, the folate-peptide and DylightTM 800 was conjugated via maleimide chemistry (thioether 
linkage). The synthesis method was inexpensive and can be performed in small laboratories. The 
main advantage of this synthetic approach is that folate-peptide is very stable and can be stored 
for a long time and can be scaled to 0.5 gram batches.   
The purification of Folate-DylightTM 800 conjugate was accomplished using reversed 
phase HPLC. Total run time was 1 hour (60 mins). For the analytical run, 10 µl injection of the 
product was injected in HPLC and analyzed. Peaks were observed at 11.4 min, 15.9 min, 16.4 
min, 17, 5 min, 18.6 min. From these peaks, the sample from peaks at 17.5 min and 18.6 min 
were collected and stored it in the vials and these purified samples we injected 10 µl each in the 
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HPLC for analysis. Also UV-Vis of the collected fractions were assessed using a spectral scan in 
a UV/ViS micro-plate reader. In the HPLC chromatogram, at 17.7 min we observed the 
unreacted folate cysteine peak, the compound folate dylight 800 peak at 21.1 min and the 
unreacted dye peak at 32.3 min (Figure-6). At 18.6 min we have clearly observed few peaks 
with small intensities. It is largely anticipated that the compound at 21.2 min is folate dylight 800 
(Figure-7).  
By using the microplate reader we observed the characteristic Dylight 800 peak at around 790 
nm. We also observed the characteristic folate doublet at 280 and 363 nm. The spectrum is 
displayed in Figure-8. 
 
Conclusion: 
Folate-DylightTM 800 was successfully synthesized by very simple, inexpensive and safe 
method. The whole synthesis method can be performed in small laboratories with minimum 
resources and small quantity of reagents required. The synthesis of Folate-DylightTM 800 
conjugate was successfully purified by HPLC. The purified Folate-DylightTM 800 conjugate was 
evaluated by UV-Vis and HPLC. Unfortunately, mass spectrometry was not performed due to a 
pump failure. This will be undertaken in a future project.  
 
 
 
 
 
 
 
 
   
 14 
 
                                      
    
(Figure:1) Structure of folic acid 
 
       
 
            
                            
(Figure:2) General Scheme for Folate-Dye conjugates 
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                   (Figure:3) Transportation of Folate-conjugates via Folate receptors. 
 
 
 
Product  Color mass (g/mol) Absorb (nm) Emit (nm) ε (M
-1cm-
1) 
DyLight 350 violet 874 353 432 15,000 
DyLight 405 violet 793 400 420 30,000 
DyLight 488 green 1011 493 518 70,000 
DyLight 550 yellow 982 562 576 150,000 
DyLight 594 orange 1078 593 618 80,000 
DyLight 633 red 1066 638 658 170,000 
DyLight 650 red 1008 654 673 250,000 
68 far-red 950 692 71 40, 0 
75 near-IR 1092 754 776 220, 0 
800 near-IR 50 777 794 270, 0 
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Table-1 Dylight Products 
 
 
 
 
                                                                  Excitation 
                                                                        Emission  
                
 
 
 
 
(Figure-4) Thermo Scientific Dylight 800  Properties 
 
 
     
 
 
Thermo Scientific Dylight 800 Properties 
 
Excitation(nm) 777 
Emission(nm) 794 
Color Near-IR 
€†
 
270,000 
CF‡ 0.045 
Mol.Weight(g/mol) 899.15 
Spectrally similar Dyes Alexa Fluor*790,  
IR Dye*800 
†Molar extinction coefficient (M-1 cm-1) 
‡ Correction factor(A260/A777) 
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                                                                 + 
                                             DylightTM 800 Maleimide 
                        
 
  
Folate DylightTM 800 Maleimide conjugate 
(Figure:5) Schematic Representation of Folate DylightTM 800 Maleimide conjugate 
synthesis 
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(Figure:6) Chromatogram of crude Folate-DylightTM 800 
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(Figure: 7) Chromatogram of purified Folate-DylightTM 800 conjugates at 21.1 min. 
 
 
 
 
 
 
 
 
 
 20 
 
 
 
 
 
 
(Figure : 8) UV-Vis of Folate-DylightTM 800 conjugates 
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